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Furocoumarins (psoralen and its derivatives) are used 
to photoinactivate a variety of viruses and cell types. In 
the presence of long-wavelength ultraviolet light (UVA), 
furocoumarins bind covalently with pyrimidine residues 
via a cyclobutane ring. A second photoevent allows py­
rimidines located on the opposite DNA strand in an 
adjacent base pair to react, forming a cross-link. In the 
experiments in this report, psoralen photoinactivation 
is employed to investigate human DNA repair pathways 
by analyzing the ability of xeroderma pigmentosum (XP) 
and Fanconi's anemia (FA) cells to rescue psoralen­
inactivated herpes simplex virus (HSV). Comparison of 
several XP complementation groups and one XP variant 
with normal human fibroblasts demonstrates that the 
ability of all cells to repair damage by 4,5' ,8-trimethyl­
psoralen (TMP), a derivative that forms cross-links ef­
ficiently, is similar. However, HSV photochemically re­
acted with 5-methylangelicin (5-MA), an isopsoralen 
that forms only monoadducts, is repaired at significantly 
lower levels in several XP complementation groups than 
in control fibroblast cells, which indicates that the XP 
repair deficiency resides in the removal of monoadducts 
and not of cross-links in these cell lines. Surprisingly, 
the FA cells rescue both TMP- and 5-MA-treated virus 
with slightly greater efficiency than tbat observed in 
normal human fibroblasts. 
Human fibroblasts from patients with DNA repair defects 
provide a valuable tool for the elucidation of eukaryotic DNA 
repair pathways [1,2]. Xeroderma pigmentosum (XP) and Fan­
coni's anemia (FA) are two autosomal recessive diseases cor­
related with DNA repair deficiencies_ XP causes severe photo­
sensitivity of exposed regions and a high incidence of skin 
cancer (basal cell carcinoma, squamous carcinomas, and malig-
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Abbreviations: 
DMEM: Dulbecco's modified Eagle's medium 
FA: Fanconi's anemia 
FCS: fetal calf serum 
HSV: herpes simplex virus 
HSV -1: herpes simplex virus type 1 
5-MA: 5-methylangelicin 
MEME: minimal essential medium (Eagle's) 
MMC: mitomycin C 
8-MOP: 8-methoxypsoralen 
NEAA: nonessential amino acids 
NM: nitrogen mustard 
PFUs: plaque-forming units 
SV40: simian virus 40 
TMP: 4,5',8-trimethylpsoralen 
UDS: unscheduled DNA synthesis 
UV A: long-wavelength ultraviolet light 
XP: xeroderma pigmentosum 
nant melanomas) [2,3J. FA is a progressive pancytopenia with 
early onset of thrombocytopenia followed by leukopenia and 
finally aplastic anemia [2]. 
Genetic studies with XP fibroblasts and cell fusion tech­
niques indicate that at least seven complementation groups (A­
G) and one variant group exist [4-7]_ Fibroblasts from all 
complementation groups except the variant exhibit reduced 
levels of excision repair after UV irradiation [2J. XP variants 
have near normal or normal levels of excision repair of pyrim­
idine dimers, but are defective in the postreplication repair 
pathway [7]. Virus inactivation kinetics of UV -irradiated sim­
ian virus 40 (SV40), herpes simplex virus type 1 (HSV-l), and 
adenovirus in XP fibroblasts are decreased relative to normal 
fibroblasts [8-11]_ Survival of XP fibroblasts after exposure to 
ionizing radiation is normal or slightly reduced when compared 
with normal fibroblasts [2], although the survival of gamma­
irradiated adenovirus was reduced in XP fibroblasts [12J. XP 
fibroblasts are hypersensitive to certain chemicals that form 
large adducts to DNA, such as acetylaminofluorene and nitro­
quinoline oxide. In contrast, they demonstrate a normal re­
sponse to small alkylating agents, such as N-methyl-N-nitro­
N-nitrosoguanidine, methyl methanesulfonate, ethyl methane 
sulfonate, and cross-linking agent mitomycin C (MMC) 
[2,13]. However, it was reported that adenovirus treated with 
nitrous acid, 4,5' -8-trimethylpsoralen (TMP), or chloroprom­
azine resulted in decreased survival in XP cells [14-16]. 
Fibroblasts from patients with Fanconi's anemia exhibit an 
increased susceptibility to chromosomal breakage when ex­
posed to a variety of bifunctional compounds, such as MMC, 
nitrogen mustard (NM), and 8-methoxypsoralen (8-MOP) [2J. 
Survival curves consistently indicate an increased sensitivity 
to the cross-linking agent MMC [17,18]. In contrast, reports 
concerning the removal of cross-links by FA fibroblasts have 
presented conflicting results. One group reported a 2- to 8-fold 
reduced rate of cross-link repair for three FA fibroblast cell 
lines (FA9TO, FA14TO, FA12TO) [17], while two other groups 
using two different FA fibroblast cell lines (HG-261 and CRL-
1196) found that there was no defect in their ability to remove 
the bifunctional compounds MMC and 8-MOP, respectively 
[18,19J. In the second report, however, the short irradiation 
time employed may have resulted in 8-MOP binding primarily 
as monoadduct. Recently, it was reported that FA cell senes­
cence may play a role in whether or not NM cross-links are 
repaired. Early passage cultures of FA fibroblasts (FA9, FA18) 
previously reported to be defective in the removal of MMC 
cross-links were found to repair NM cross-links, while the same 
FA fibroblasts grown to late passages lost most of this capacity 
[20J. 
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This paper will present results comparing the ability of XP 
and FA fibroblasts to repair DNA damage induced by furoc0u­
marins plus UV A_ Furocoumarins readily intercalate between 
the stacked DNA bases of intact cells or viruses without result­
ing in DNA damage. Once bound and in the presence of UVA 
(320 to 420 nm), these drug molecules react covalently with 
pyrimidine residues to form monoadducts or cross-links [21-
23]_ Although there are approximately two to three times more 
monoadducts than cross-links ([24] and Wiesehahn and Hal-
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lick, unpublished observations), cross-links are thought to be 
responsible for virus inactivation, cell killing, mutagenesis, loss 
of tumorigenicity in transformed cells, and increased rates of 
recombination in phage-prophage crosses [21,25-29]. Experi­
ments utilizing psoralen derivatives such as angelicin, an iso­
psora len that does not produce cross-links, and khellin, which 
forms them infrequently, also implicate monoadducts in cell 
killing and virus inactivation, although they are considerably 
less effective then psoralen cross-linking derivatives [21,30]. 
During the past few years, severe cases of psoriasis have been 
treated with considerable success by the combination of 8-MOP 
and UVA (the PUVA treatment) [21]. It was suggested by Dr. 
Hanawalt at these meetings 3 years ago that the treatment of 
PUVA patients with drugs that efficiently cross-link DNA, 
perhaps with an additional irradiation in the absence of drug, 
might enhance the ability to kill (psoriatic) cells with cross­
links and minimize the probability of monoadduct repair via 
an "error-prone" pathway, thereby decreasing the possibility of 
malignant transformation. We subsequently examined the fea­
sibility of this suggestion by analyzing the photoinactivation 
kinetics of bacteriophage lambda, which is extremely sensitive 
to psoralen killing, and the papovavirus SV 40, which is rela­
tively resistant to psoralen photoinactivation [29]. Results from 
the two virus-host systems were quite different. In experiments 
designed to measure the effects of cross-links, aliquots of psor­
alen-treated virus were reirradiated in the absence of drug. In 
the case of lambda, reirradiation resulted in an inactivation 
rate virtually identical to that observed in the continuously 
irradiated samples. This indicates that cross-link formation 
can account for nearly all lambda inactivation observed in this 
region of the curve. However, when the same approach was 
extended to SV 40, the resulting rate of inactivation was consid­
erably less in the reirradiated samples than in those treated 
continuously in the presence of drug. This relative resistance 
may imply that monoadduct formation is rate-limiting in this 
system, perhaps due to protection of the DNA afforded by 
histones in the virion [31,32]. Alternatively, the repair capacity 
of the eukaryotic host cell may differ markedly from that of 
the prokaryotic host Escherichia coli. 
Although many chemical agents, including the furocoumarin 
TMP, have been utilized to study the defective repair mecha­
nisms of XP and FA fibroblasts, none compares to the removal 
of monoadducts and crosfi-links, particularly with compounds 
that bind to DNA by similar mechanisms. These experiments 
were designed to examine the kinetics of HSV photoinactiva­
tion by the cross-linking psoralen derivative TMP and by the 
isopsoralen derivative 5-methylangelicin (5-MA), which only 
forms monoadducts. The ability of normal human, XP, and FA 
fibroblasts to repair viral DNA damaged by psoralen cross­
links or monoadducts was assessed by titering the inactivated 
virus in parallel on each cell type. One normal human cell line 
was examined along with one representative of each of the XP 
complementation groups A-G, the XP variant, and one FA cell 
line. Results indicate that all XP cell types examined repair 
TMP adducts in the viral DNA as efficiently as the normal 
control cells. Surprisingly, it was observed that the FA cell line 
is better able to repair TMP photoadducts than normal fibro­
blasts. Kineticfi of 5-MA inactivation of HSV -1 demonstrated 
that many representatives of the XP complementation groups 
were less capable of monoadduct repair of viral DNA than the 
normal fibroblasts or XP variant cells. While several XP cell 
strains were very sensitive to 5-MA addition, consistent with 
the reported decrease in unscheduled DNA synthesis (UDS) 
after UV irradiation, other XP fibroblasts did not show a 
corresponding decrease. The overall repair pathway or some 
step(s) in the pathway may not occur at the same rate for the 
removal of pyrimidine dimers as for that of 5-MA monoadducts. 
Both FA cells and the XP2RO cells representing complemen­
tation group E were found to repair 5-MA monoadducts more 
efficiently than normal cells. The reason for this is unclear, but 
group E has been reported to have a 40-60% capacity for 
excision repair relative to normal control cells. HSV -1 photo­
reacted with TMP appeared to undergo multiplicity of reacti­
vation when plaqued on all XP and FA cells. This phenomenon 
was not evident for HSV-1 photoreacted with 5-MA and 
plaqued on XP or FA cells. 
MATERIALS AND METHODS 
Human Cell Lines and Growth Medium 
Xeroderma pigmentosum primary cells XPlOBE (CRL 1204), 
XP6BE (CRL 1157), XP4BE (CRL 1162), and XPl2BE (CRL 1223), 
normal human control skin fibroblast (CCD-25SK (CRL 1474), and 
Fanconi's anemia cells HG-261 (CCL 122) were obtained from the 
American Type Culture Collection. Xeroderma pigmentosum primary 
ce1l8 XP3YO (GM 3542), XP2B1 (GM 3021A), and GM 1854 were 
purchased from N.I.G.M.S. Human Genetic Mutant Cell Respository. 
Primary cells XP10BE, XP6BE, XP12BE, and XP4BE were cultured 
in Dulbecco's modified Eagle's medium (DMEM) (Gibco) supple­
mented with 44 mM NaHC03 and 10% fetal calf serum (FCS). Mini­
mum essential medium (Eagle's) (MEME) (Flow Laboratories, Inc.) 
supplemented with 2.0 mM L-glutamine, 23.8 mM NaHC03, and 2X 
concentration of nonessential amino acids (NEAA), amino acids, and 
vitamin solutions plus 10% FCS was used for the culture of primary 
cells XP2B1, XP3YO, GM 1854, XP2RO, and HG-261. CCD-25SK 
was cultured in MEME supplemented with IX NEAA, 2.0 mM L­
glutamine, 23.8 mM NaHC03, and 10% FCS. The SV40-transformed 
XP12BE xeroderma pigmentosum cell line derived from XP12BE 
(ATCC CRL 1223) primary cell line was provided by W. Summers and 
cultured in DMEM with 10% FCS and 44 mM NaHCO". All culture 
media contained penicillin and streptomycin in final concentrations of 
100 U/ml and 50 J.Lg/ml, respectively. 
Viru� Stocks and Furocoumarins 
Herpes simplex virus type 1 (CIlOl HSV-1) was kindly provided by 
W. Summers. HSV-1 was propagated in Vero (African green monkey 
kidney) cells at a multiplicity of infection of 0.01 plaque-forming units 
(PFUs) per cell. A single virus stock stored at -70°(; was utilized ,� all 
experiments. 
4,5' ,8-Trimethylpsoralen (TMP) [33] and 5-methylangelicin (5-l\1A) 
[341 were generously provided by S. Isaacs and J. Hearst. Stock solu­
tions in ethanol were stored at room temperature in the dark. Drug 
concentration was calculated from the extinction coefficient by meas­
uring the absorbance at 249 nm in aqueous solution. 
Irradiation Experiment� 
Stock HSV-1 in MEME with 2% FCS was adjusted to a final 
concentration of 0.01 J.Lg/ml TMP, 0.10 J.Lg/ml TMP, or 2.0 J.Lg/ml 5-
MA. Drug-virus solutions were held at 4°C in the dark for 20 min or 
longer. All irradiations were done on a single bank of two General 
Electric F15T8BLB fluorescent bulbs at the average incident light 
intensity indicated in the figure legends. The degree of incident inten­
sity was controlled by use of Plexiglas shields. Virus-drug samples were 
irradiated in separate 35-mm tissue culture dishes (Corning) in 100-J.Ll 
aliquots for each time point. Controls for all experiments consisted of 
vints plus drug without irradiation (0 min) and virus with UV A alone 
for the maximum time used in each experiment. 
Each time point was serially diluted in MEME with 2% FCS and 
adsorbed to cell monolayers in 35-mm tissue culture dishes for 60 min 
at 37°C. Monolayers were then overlayed with 0.5% (w/v) methyl 
cellulose in MEME with 5% FCS and incubated at 3TC for 4 days. At 
this time, all plates were fixed and stained for plaque enumeration. All 
graphs depicting kinetic photo inactivation of HSV-1 have been nor­
malized to the control samples containing TMP or 5-MA without 
irradiation (0 min). The experiments depicted in Figs 2-4 have been 
repeated two to three times with similar results; for ease of presentation, 
only one complete experiment is shown. 
RESULTS 
The Effects of Psoralen Monoadducts and Cross-Links on 
HS V-J Viability When Assayed on XP Cells 
In order to compare the repair pathways of XP cells with 
those of normal cells, HSV-1 was photoinactived with both 
TMP and 5-MA at relatively high light intensities. The results 
are depicted in Fig 1. As shown in Fig la, the effect of TMP 
on the inactivation kinetics of HSV -1 in the repair-deficient 
human cell types XP12BE (A), XP2RO (E), XP4BE (variant, 
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FIG 1. Comparison of TMP and 5-MA photo inactivation kinetics 
of HSV -1 at an average incident light intensity of 2.8 m W /cm2 when 
assayed on normal human and xeroderma pigmentosum cells. Virus 
suspensions were treated with TMP or 5-MA plus UVA for varying 
periods of time up to 60 min. Titration of HSV -1 was determined by 
the plaque assay method for each time point using the following cell 
lines: normal human control CCD-25SK (NC, .) , XP14BE variant (V, 
0), XP1:1BE (A, x), XP6BE (D,.), and XP2RO (E, . ) . a, Photoinac ­
tivation kinetics of HSV -1 exposed to O.Olllg/ml TMP plus UV A. The 
normalized value indicated as less than «) for the XP12BE cell line 
at 30 min irradiation time represents the limit of detection by the 
plaque assay. b, Photoinactivation kinetics of HSV-1 exposed to 2.0 
Ilg/ml fi-MA plus UVA. Normalized values indicated as less than «) 
for the XP6BE and XP12BE cell lines at 20 min irradiation time 
represent the limit of detection by the plaque assay. 
V), and CCD-25SK (normal control, NC) is similar. There may 
be a slight defect in host-cell reactivation in cells of comple­
mentation group D (XP6BE). 
In contrast, a marked difference in the titers of 5-MA-treated 
HSV (Fig 1b) is seen when assayed on XP12BE (A) or XP6BE 
(1)) cells, implying a defect in monoadduct repair. XP2RO (E) 
and XP4BE (V) cells are similar to CCD-25SK (NC) cells. 
TMP Photoinactivation Kinetics of HSV- J 
The observations described above were extended to all of XP 
complementation groups and to cells from a patient with Fan­
coni's anemia. In addition, higher initial virus titers were em­
ployed to enable us to follow the kinetics over a greater time 
period. Published data concerning the ability of XP and FA 
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TABLE I. Lccels of UV-inducpd un:ichedulcd DNA :iynthesis ill 
normal, xemderma plf,;mentosum, and Fanconi's anemia fibroblast cell 
lines 
Cell line Complementation Percent UDS" References group 
CCD-25SKb NC 100 
XP4BEc V 100 [2] 
XP12BE A <2 [2,35] 
XP12BE-SV40d A-SV40 
GM 1854' B-H 100 [2, 35 1 
XPlOBE C 10-20 [2,3] 
XP6BE D 25-50 [2,351 
XP2RO E 40-60 [2, 36] 
XP3YO F 10 [37] 
XP2B1 G <2 [2,6] 
HG-261 FN 100 [17] - ----------
"Percent UV-induced unscheduled DNA synthesis. 
b Normal human control skin fibroblast cells. 
'Fibroblast cells from a patient with diagnosed XP that exhibit 
normal UDS but defective postreplication repair. 
d SV40.transformed XP12BE fibroblast cells. 
,. Heterozygous complementation group B fibroblast cells. 
t Fanconi 's anemia hbrobl<lst cells. 
S-H _c A-SV40 -NC 
• G,<370XIO-1 
10-64-------,------.------,------,-------
o 10 20 30 40 
I R R A D I A T ION TIM E (min) 
FIG 2. Comparison of TMP photoinactivation kinetics of HSV·j 
assayed on normal human control, xeroderma pigmentosum, and Fan· 
coni's anemia cells. Virus suspensions were exposed to O.lllg/ml TMP 
plus UV A for varying periods of time up to 60 min. HSV -1 was 
quantitated by the plaque assay method for each time point using the 
following cells: normal human control CCD-25SK (NC, .) , XP4BE 
variant (V, 0), XP12BE-SV40 (A-SV40, 0), GM 1854 (B-H, t,), 
XP10BE (C, 0), XP6BE (D, . ) , XP2RO (E, . ) , XP3YO (F, A), 
XP2Bl (G, T), and HG-261 Fanconi's anemia (FA, \7), Photoinactj· 
vation kinetic curves for all cell strains are depicted only to 40 min 
irradiation time. At later times, multiplicity reactivation hindered virus 
titration. Normalized time points indicated as less than «) for XP6BE, 
XP3YO, and XP2B1 cells represent the limit of detection by the plaque 
assay method due to multiplicity of reactivation. Average light intensity 
was 0.9 mW/cm2• 
fibroblasts to repair DNA damage produced by various cross· 
linking agents has not consistently demonstrated a defect in 
these cell types [2,13,15,17-19]. A detailed investigation of the 
kinetics of TMP photoinactivation of HSV -1 was undertaken 
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in XP and FA cells. The levels of UV-induced UDS reported 
for these cell types is summarized in Table I. The inactivation 
curves of such experiments are depicted in Fig 2. All cell lines 
tested demonstrate that repair of TMP-damaged virion DNA 
promotes virus multiplicity reactivation (nonlinear dilution 
series at multiplicites greater than 2 to 10 ) . This phenomenon 
was not observed in the experiments presented in Fig 1, pre­
sumably because of the lower initial virus titer. FA cell line 
HG·261 was consistently found to have a slightly increased 
ability to repair TMP adducts over the normal control cell line 
CCO-25SK. In most, experiments, the ability of different XP 
complementation groups to repair TMP adducts appeared 
equivalent to that of normal control cells. Differences at the 
late time points (40 and 60 min) are difficult to interpret 
because of the apparent ability of HSV -1 to be reactivated by 
recombination at high multiplicities. This point will be exam­
ined in more detail in the Discussion. 
5·MA Photoinactivation Kinetics of HSV-I 
Photo inactivation kinetics of HSV -1 by 5-MA are depicted 
in Figs 3 and 4. Cell lines HG-261 (FA), XP2RO (E), and GM 
1854 (heterozygous, B-H) repair 5-MA monoadducts as effi­
ciently or slightly better than the CCD-25SK (NC) and XP4BE 
(V) cells (Fig 3). Although differences in HSV -1 inactivation 
rates are slight, the results with the HG-261, XP2RO, and GM 
1854 cells were consistently observed to fall above that of CCD-
25SK. All cell lines depicted in Fig 3 demonstrate a linear 
response to 5-MA photoinactivation of HSV -1. Photoinactiva­
lion kinetics of HSV-l by 5-MA when assayed on XP12BE 
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FIG 3. Comparison of 5-MA photo inactivation kinetics of HSV-1 
assayed on cells with no apparent repair deficiencies. Virus suspension 
were exposed to 2.0 I'g/ml 5·MA plus UVA for varying periods of time 
up to 60 min. HSV·1 infectivity was determined by the plaque assay 
method for each time point using the following cells: normal human 
control CCD-25SK (NC, e), XP4BE variant (V, 0), GM1854 (E-H, 
il), XP2RO (E, +), and HG-261 Fanconi's anemia (FA, \7). Average 
light intensity was 2.3 m W /cm'. 
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FIG 4. Comparison of 5-MA photoinactivation kinetics of HSV-l 
assayed on normal human control cells and xerodema pigmentosum 
cells deficient in monoadduct repair. Virus suspensions were exposed 
to 2.0 I'g/ml 5-MA plus UVA for varying periods of time up to 60 min. 
HSV -1 was quantitated by the plaque assay method for each time point 
on the following cells: normal human control CCD-25SK (NC, e), 
XP12BE (A, x), XP12BE-SV40 (A-SV40, 0), XP10BE (C, 0), XP6BE 
(D, . ) , XP3YO (F, A), andXP2Bl (G, 'Y). Normalized values indicated 
as less than «) for XP12BE, XPlOBE, and XP2Bl cells at the 60 min 
irradiation time represent the limits of detection by the plaque assay 
method. Average light intensity was 2.3 mW/cm'. 
(A), and XPI2BE-SV40 (transformed,A-SV40), XPlOBE (C), 
XP6BE (D), XP3YO (F), and XP2B1 (G) are depicted in Fig 
4. The data from normal fibroblasts is repeated from Fig 3. All 
experiments in Figs 3 and 4 were conducted at the same time, 
but they are plotted separately for ease of presentation. Two 
observations can be made from these results. First, XP12BE 
(A), XP12BE-SV40 (A-SV40), and XP2B1 (G) are the most 
sensitive to 5-MA damage of HSV-1 and demonstrate linear 
inactivation kinetics. Second, cell lines XP10BE (C), XP6BE 
(D), and XP3YO (F) exhibit intermediate sensitivity to 5-MA 
damage of HSV-1 when compared with normal control cells 
and the more repair deficient cells of complementation groups 
A and G. In addition , HSV-1 inactivation kinetics assayed on 
this group (C, D, and F in Fig 4) consistently demonstrate a 
break in the linear curve between 30 and 50 min of irradiation. 
No evidence of multiplicity reactivation of 5-MA-inactivated 
HSV -1 was observed in any of the cells studied. 
DISCUSSION 
The kinetics of HSV -1 photoinactivation demonstrate that 
all XP cells tested repair TMP cross-links to approximately 
the same extent as the normal control cell line CCD-25SK 
(Figs 1 and 2). In contrast to these observations , the XP cell 
types from the complementation groups tested exhibit quite 
different 5-MA photoinactivation kinetics of HSV -1. Cell lines 
XP12BE (A), XP12BE-SV40 (A-SV40), and XP2Bl (G) are 
the most deficient in monoadduct repair, an observation con-
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sistent with their low level of UV -induced UDS (see Table I). 
Monoadduct repair by fibroblasts XPI0BE (C), XP6BE (D), 
and XP3YO (F) is moderately deficient and compares with the 
reported levels of 10-50% UV -induced UDS. The same rate of 
HSV -1 reactivation is observed on the XP4BE (V) and CCD-
25SK (NC) cells. Complementation group B heterozygous cell 
line GM 1854 (B-H) repairs 5-MA monoadducts as efficiently 
or better than the normal control cell line CCD-25SK. XP2RO 
(E) exhibits a 40-60% UV-induced UDS [2,36], yet has con­
sistently resulted in a slightly hi�her rate of host-cell virus 
reactivation wh:m compared with CCD-25SK (NC). 
Reports in the literature suggest that the repair of cross-links 
generated by 8-MOP does not occur in XP12BE (A) [19] and 
XPI (XPILO, A) cells [38], although results of TMP photo­
inactivation of HSV -1 show that the ability of all XP cells 
examined to repair damaged virus is comparable with that seen 
in normal control cells (CCD-25SK). Initial experiments using 
high concentrations of TMP (1.0 J.Lg/ml) and a high incident 
light intensity (2.7 mW/cm") resulted in a 5.0-10g decrease in 
HSV-1 titer within 5 min. In such an experiment, a difference 
in HSV-l titers of 1-2 logs is observed between XP12BE (A) 
and CCD-25SK (NC). At such short irradiation times, a high 
percentage of the bound drug molecules are probably still 
monoadducts, as has been demonstrated in the lambda system 
by reirradiation experiments [29]. Thus these data support the 
conclusion that the repair defect in XP cells resides in the 
excision repair of psoralen monoadducts [15,39], while the 
repair of cross-links is limited and most likely represents a 
lethal event in eukaryotes [26,39-40]. 
HSV-l treated with either 5-MA or TMP consistently dem­
onstrates a greater sensitivity to photoinactivation when as­
sayed on the normal control cell line CCD-25SK than when 
titered on FA cells. This does not merely reflect differences in 
plaquing efficiency , since the data are normalized at the 0 time 
point. Although current literature and this report present con­
flicting evidence as to the ability of FA cells to repair cross­
linking agents, several explanations may account for these 
apparent discrepancies [17-20]. It is possible that a virus-coded 
recombination pathway and/or the nonnucleosomal structure 
of intracellular HSV DNA may facilitate repair of both mon­
oadducts and cross-links [41-43]. This explanation is consist­
ent with our observation that TMP induces a high degree of 
virus multiplicity reactivation in normal control, FA, and XP 
human cells . Surprisingly, it is not observed in Vero cells (data 
not shown). However, we were unable to detect any multiplicity 
of reactivation of 5-MA photo inactivated HSV-l plaqued on 
FA, XP, or normal control cells. An alternative explanation is 
that the FA cell line HG-261 reported in this paper is not 
defective in TMP cross-link removal in spite of its sensitivity 
to MMC cross-links [18]. It is interesting to note that the FA 
cell line reported in this paper was tested between passages 42 
and 45, which is well past passage numbers reported to be 
defective in NM cross-link removal from cellular DNA [20]. 
In conclusion, the repair of TMP adducts on HSV -1 DNA 
by all XP complementation groups and the XP variant exam­
ined occurs with an efficiency similar to that of normal control 
cells and may involve HSV-1 recombination. Several XP com­
plementation groups tested are defective to varying degrees in 
5-MA repair , although XP2RO (E) cells are able to repair 
monoadducts as efficiently as normal cells. The FA cells (HG-
261) examined are able to repair both 5-Ma and TMP photo­
inactivated HSV -1 somewhat more efficiently than the normal 
cells used in this study. 
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